Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia

NCT02215629 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Relapsed or Refractory Acute Myeloid Leukemia
Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Interventions

DRUG: VS-4718

Sponsor

Verastem, Inc.